SVB Wealth LLC Buys 786 Shares of Aflac Incorporated (NYSE:AFL)

SVB Wealth LLC grew its stake in shares of Aflac Incorporated (NYSE:AFL) by 7.6% in the fourth quarter, HoldingsChannel.com reports. The fund owned 11,156 shares of the financial services provider’s stock after acquiring an additional 786 shares during the quarter. SVB Wealth LLC’s holdings in Aflac were worth $920,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. BKM Wealth Management LLC bought a new stake in shares of Aflac during the 4th quarter valued at $1,558,000. Nordea Investment Management AB lifted its position in shares of Aflac by 25.9% during the 4th quarter. Nordea Investment Management AB now owns 1,693,249 shares of the financial services provider’s stock valued at $139,676,000 after acquiring an additional 348,400 shares during the period. G&S Capital LLC lifted its position in shares of Aflac by 65.1% during the 4th quarter. G&S Capital LLC now owns 31,825 shares of the financial services provider’s stock valued at $2,626,000 after acquiring an additional 12,551 shares during the period. DekaBank Deutsche Girozentrale lifted its position in shares of Aflac by 7.5% during the 4th quarter. DekaBank Deutsche Girozentrale now owns 376,087 shares of the financial services provider’s stock valued at $30,786,000 after acquiring an additional 26,338 shares during the period. Finally, Kestra Private Wealth Services LLC lifted its position in shares of Aflac by 12.7% during the 3rd quarter. Kestra Private Wealth Services LLC now owns 48,745 shares of the financial services provider’s stock worth $3,741,000 after buying an additional 5,477 shares during the last quarter. 67.44% of the stock is currently owned by institutional investors.

Insider Activity

In other news, SVP Albert Riggieri sold 8,000 shares of the stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $83.34, for a total value of $666,720.00. Following the completion of the sale, the senior vice president now owns 32,825 shares of the company’s stock, valued at $2,735,635.50. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, SVP Albert Riggieri sold 8,000 shares of the stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $83.34, for a total value of $666,720.00. Following the completion of the sale, the senior vice president now owns 32,825 shares of the company’s stock, valued at $2,735,635.50. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Arthur Reginald Collins sold 3,000 shares of the stock in a transaction dated Thursday, February 22nd. The shares were sold at an average price of $79.73, for a total value of $239,190.00. Following the completion of the sale, the director now directly owns 5,592 shares of the company’s stock, valued at approximately $445,850.16. The disclosure for this sale can be found here. Over the last quarter, insiders sold 46,493 shares of company stock valued at $3,765,706. Company insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

Several analysts recently weighed in on the company. UBS Group upped their price objective on Aflac from $80.00 to $84.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 10th. Evercore ISI downgraded Aflac from an “in-line” rating to an “underperform” rating and upped their price objective for the stock from $76.00 to $78.00 in a research report on Thursday, January 4th. Keefe, Bruyette & Woods upped their price objective on Aflac from $83.00 to $87.00 and gave the stock a “market perform” rating in a research report on Wednesday, April 10th. Raymond James upped their price objective on Aflac from $83.00 to $88.00 and gave the stock an “outperform” rating in a research report on Friday, February 2nd. Finally, StockNews.com downgraded Aflac from a “hold” rating to a “sell” rating in a research report on Wednesday, April 10th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $82.15.

Aflac Price Performance

Shares of AFL opened at $83.23 on Friday. Aflac Incorporated has a 12-month low of $64.10 and a 12-month high of $86.26. The business has a 50-day simple moving average of $82.21 and a two-hundred day simple moving average of $81.50. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.33. The stock has a market cap of $47.89 billion, a PE ratio of 10.74, a PEG ratio of 2.20 and a beta of 0.91.

Aflac (NYSE:AFL) last issued its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.25 earnings per share for the quarter, missing the consensus estimate of $1.47 by ($0.22). The company had revenue of $3.78 billion during the quarter, compared to analyst estimates of $4.44 billion. Aflac had a net margin of 24.92% and a return on equity of 17.59%. During the same period in the previous year, the company posted $1.29 EPS. Analysts anticipate that Aflac Incorporated will post 6.41 earnings per share for the current fiscal year.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.